Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 73 entries
Sorted by: Best Match Show Resources per page
Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder.

Pharmacogenomics and personalized medicine

Zastrozhin MS, Grishina EA, Denisenko NP, Skryabin VY, Markov DD, Savchenko LM, Bryun EA, Sychev DA.
PMID: 29988737
Pharmgenomics Pers Med. 2018 Jun 29;11:113-119. doi: 10.2147/PGPM.S160763. eCollection 2018.

BACKGROUND: Fluvoxamine therapy is used for treatment of patients with depressive disorder, but it is often ineffective, and some patients suffer from dose-dependent undesirable side effects such as vertigo, headache, indigestion, xerostomia, increased anxiety, etc. CYP2D6 is involved in...

Cite
Zastrozhin MS, Grishina EA, Denisenko NP, et al. Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder. Pharmgenomics Pers Med. 2018;11:113-119doi: 10.2147/PGPM.S160763.
Zastrozhin, M. S., Grishina, E. A., Denisenko, N. P., Skryabin, V. Y., Markov, D. D., Savchenko, L. M., Bryun, E. A., & Sychev, D. A. (2018). Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder. Pharmacogenomics and personalized medicine, 11113-119. https://doi.org/10.2147/PGPM.S160763
Zastrozhin, Mikhail Sergeevich, et al. "Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder." Pharmacogenomics and personalized medicine vol. 11 (2018): 113-119. doi: https://doi.org/10.2147/PGPM.S160763
Zastrozhin MS, Grishina EA, Denisenko NP, Skryabin VY, Markov DD, Savchenko LM, Bryun EA, Sychev DA. Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder. Pharmgenomics Pers Med. 2018 Jun 29;11:113-119. doi: 10.2147/PGPM.S160763. eCollection 2018. PMID: 29988737; PMCID: PMC6029588.
Copy Download .nbib Format: NLM
NLRP7 variants in spontaneous abortions with multilocus imprinting disturbances from women with recurrent pregnancy loss.

Journal of assisted reproduction and genetics

Sazhenova EA, Nikitina TV, Vasilyev SA, Tolmacheva EN, Vasilyeva OY, Markov AV, Yuryev SY, Skryabin NA, Zarubin AA, Kolesnikov NA, Stepanov VA, Lebedev IN.
PMID: 34554362
J Assist Reprod Genet. 2021 Nov;38(11):2893-2908. doi: 10.1007/s10815-021-02312-z. Epub 2021 Sep 23.

PURPOSE: Comparative analysis of multilocus imprinting disturbances (MLIDs) in miscarriages from women with sporadic (SPL) and recurrent pregnancy loss (RPL) and identification of variants in the imprinting control gene NLRP7 that may lead to MLIDs.METHODS: Chorionic cytotrophoblast and extraembryonic...

Cite
Sazhenova EA, Nikitina TV, Vasilyev SA, et al. NLRP7 variants in spontaneous abortions with multilocus imprinting disturbances from women with recurrent pregnancy loss. J Assist Reprod Genet. 2021;38(11):2893-2908doi: 10.1007/s10815-021-02312-z.
Sazhenova, E. A., Nikitina, T. V., Vasilyev, S. A., Tolmacheva, E. N., Vasilyeva, O. Y., Markov, A. V., Yuryev, S. Y., Skryabin, N. A., Zarubin, A. A., Kolesnikov, N. A., Stepanov, V. A., & Lebedev, I. N. (2021). NLRP7 variants in spontaneous abortions with multilocus imprinting disturbances from women with recurrent pregnancy loss. Journal of assisted reproduction and genetics, 38(11), 2893-2908. https://doi.org/10.1007/s10815-021-02312-z
Sazhenova, Elena A, et al. "NLRP7 variants in spontaneous abortions with multilocus imprinting disturbances from women with recurrent pregnancy loss." Journal of assisted reproduction and genetics vol. 38,11 (2021): 2893-2908. doi: https://doi.org/10.1007/s10815-021-02312-z
Sazhenova EA, Nikitina TV, Vasilyev SA, Tolmacheva EN, Vasilyeva OY, Markov AV, Yuryev SY, Skryabin NA, Zarubin AA, Kolesnikov NA, Stepanov VA, Lebedev IN. NLRP7 variants in spontaneous abortions with multilocus imprinting disturbances from women with recurrent pregnancy loss. J Assist Reprod Genet. 2021 Nov;38(11):2893-2908. doi: 10.1007/s10815-021-02312-z. Epub 2021 Sep 23. PMID: 34554362; PMCID: PMC8608992.
Copy Download .nbib Format: NLM
Dose and time dependence of functional impairments in rat jejunum following ionizing radiation exposure.

Physiological reports

Livanova AA, Fedorova AA, Zavirsky AV, Bikmurzina AE, Krivoi II, Markov AG.
PMID: 34337895
Physiol Rep. 2021 Aug;9(15):e14960. doi: 10.14814/phy2.14960.

Ionizing radiation causes dramatic change in the transport and barrier functions of the intestine. The degree of radiation damage rate depends primarily on the absorbed dose and post-irradiation time. Variety of experimental protocols providing different time points and doses...

Cite
Livanova AA, Fedorova AA, Zavirsky AV, et al. Dose and time dependence of functional impairments in rat jejunum following ionizing radiation exposure. Physiol Rep. 2021;9(15):e14960doi: 10.14814/phy2.14960.
Livanova, A. A., Fedorova, A. A., Zavirsky, A. V., Bikmurzina, A. E., Krivoi, I. I., & Markov, A. G. (2021). Dose and time dependence of functional impairments in rat jejunum following ionizing radiation exposure. Physiological reports, 9(15), e14960. https://doi.org/10.14814/phy2.14960
Livanova, Alexandra A, et al. "Dose and time dependence of functional impairments in rat jejunum following ionizing radiation exposure." Physiological reports vol. 9,15 (2021): e14960. doi: https://doi.org/10.14814/phy2.14960
Livanova AA, Fedorova AA, Zavirsky AV, Bikmurzina AE, Krivoi II, Markov AG. Dose and time dependence of functional impairments in rat jejunum following ionizing radiation exposure. Physiol Rep. 2021 Aug;9(15):e14960. doi: 10.14814/phy2.14960. PMID: 34337895; PMCID: PMC8326886.
Copy Download .nbib Format: NLM
Uncovering the anti-angiogenic effect of semisynthetic triterpenoid CDDO-Im on HUVECs by an integrated network pharmacology approach.

Computers in biology and medicine

Markov AV, Odarenko KV, Ilyina AA, Zenkova MA.
PMID: 34802714
Comput Biol Med. 2021 Nov 14;105034. doi: 10.1016/j.compbiomed.2021.105034. Epub 2021 Nov 14.

AIM: To reveal the molecular mechanism of anti-angiogenic activity of semisynthetic triterpenoid CDDO-Im.MATERIALS AND METHODS: Using re-analysis of cDNA microarray data of CDDO-Im-treated human vascular endothelial cells (HUVECs) (GSE71622), functional annotation of revealed differentially expressed genes (DEGs) and analysis...

Cite
Markov AV, Odarenko KV, Ilyina AA, et al. Uncovering the anti-angiogenic effect of semisynthetic triterpenoid CDDO-Im on HUVECs by an integrated network pharmacology approach. Comput Biol Med. 2021;105034doi: 10.1016/j.compbiomed.2021.105034.
Markov, A. V., Odarenko, K. V., Ilyina, A. A., & Zenkova, M. A. (2021). Uncovering the anti-angiogenic effect of semisynthetic triterpenoid CDDO-Im on HUVECs by an integrated network pharmacology approach. Computers in biology and medicine, 105034. https://doi.org/10.1016/j.compbiomed.2021.105034
Markov, Andrey V, et al. "Uncovering the anti-angiogenic effect of semisynthetic triterpenoid CDDO-Im on HUVECs by an integrated network pharmacology approach." Computers in biology and medicine vol. (2021): 105034. doi: https://doi.org/10.1016/j.compbiomed.2021.105034
Markov AV, Odarenko KV, Ilyina AA, Zenkova MA. Uncovering the anti-angiogenic effect of semisynthetic triterpenoid CDDO-Im on HUVECs by an integrated network pharmacology approach. Comput Biol Med. 2021 Nov 14;105034. doi: 10.1016/j.compbiomed.2021.105034. Epub 2021 Nov 14. PMID: 34802714.
Copy Download .nbib Format: NLM
[Exercise therapy in myocardial infarctions].

Klinicheskaia meditsina

KAREVA TP, MARKOV AM.
PMID: 13152976
Klin Med (Mosk). 1954 Jan;32(1):42-52.

No abstract available.

Cite
KAREVA TP, MARKOV AM. Lechebnaia gimnastika pri infarktakh miokarda. [Exercise therapy in myocardial infarctions]. Klin Med (Mosk). 1954;32(1):42-52
KAREVA, T. P., & MARKOV, A. M. (1954). Lechebnaia gimnastika pri infarktakh miokarda. [Exercise therapy in myocardial infarctions]. Klinicheskaia meditsina, 32(1), 42-52.
KAREVA, T P, and MARKOV, A M. "Lechebnaia gimnastika pri infarktakh miokarda." [Exercise therapy in myocardial infarctions]. Klinicheskaia meditsina vol. 32,1 (1954): 42-52.
KAREVA TP, MARKOV AM. Lechebnaia gimnastika pri infarktakh miokarda. [Exercise therapy in myocardial infarctions]. Klin Med (Mosk). 1954 Jan;32(1):42-52. Undetermined. PMID: 13152976.
Copy Download .nbib Format: NLM
Surface hydrophobic amino acid residues in cellulase molecules as a structural factor responsible for their high denim-washing performance.

Enzyme and microbial technology

Gusakov AV, Sinitsyn AP, Berlin AG, Markov AV, Ankudimova NV.
PMID: 11064048
Enzyme Microb Technol. 2000 Nov 15;27(9):664-671. doi: 10.1016/s0141-0229(00)00264-7.

The denim-washing performance of six purified fungal cellulases (four endo-1,4-beta-D-glucanases and two cellobiohydrolases) was compared using a model microassay. The performance of cellobiohydrolases per mg of protein was much lower than that of endoglucanases. For endoglucanases, it varied up...

Cite
Gusakov AV, Sinitsyn AP, Berlin AG, et al. Surface hydrophobic amino acid residues in cellulase molecules as a structural factor responsible for their high denim-washing performance. Enzyme Microb Technol. 2000;27(9):664-671doi: 10.1016/s0141-0229(00)00264-7.
Gusakov, A. V., Sinitsyn, A. P., Berlin, A. G., Markov, A. V., & Ankudimova, N. V. (2000). Surface hydrophobic amino acid residues in cellulase molecules as a structural factor responsible for their high denim-washing performance. Enzyme and microbial technology, 27(9), 664-671. https://doi.org/10.1016/s0141-0229(00)00264-7
Gusakov, et al. "Surface hydrophobic amino acid residues in cellulase molecules as a structural factor responsible for their high denim-washing performance." Enzyme and microbial technology vol. 27,9 (2000): 664-671. doi: https://doi.org/10.1016/s0141-0229(00)00264-7
Gusakov AV, Sinitsyn AP, Berlin AG, Markov AV, Ankudimova NV. Surface hydrophobic amino acid residues in cellulase molecules as a structural factor responsible for their high denim-washing performance. Enzyme Microb Technol. 2000 Nov 15;27(9):664-671. doi: 10.1016/s0141-0229(00)00264-7. PMID: 11064048.
Copy Download .nbib Format: NLM
[Improvements in apparatus for amperometric titration].

Laboratornoe delo

Markov II, Titkin VP, Oborin NA.
PMID: 6160314
Lab Delo. 1980;(11):694-5.

No abstract available.

Cite
Markov II, Titkin VP, Oborin NA. Usovershenstvovanie ustanovki dlia amperometricheskogo titrovaniia. [Improvements in apparatus for amperometric titration]. Lab Delo. 1980;(11):694-5
Markov, I. I., Titkin, V. P., & Oborin, N. A. (1980). Usovershenstvovanie ustanovki dlia amperometricheskogo titrovaniia. [Improvements in apparatus for amperometric titration]. Laboratornoe delo, (11), 694-5.
Markov, I I, et al. "Usovershenstvovanie ustanovki dlia amperometricheskogo titrovaniia." [Improvements in apparatus for amperometric titration]. Laboratornoe delo vol. ,11 (1980): 694-5.
Markov II, Titkin VP, Oborin NA. Usovershenstvovanie ustanovki dlia amperometricheskogo titrovaniia. [Improvements in apparatus for amperometric titration]. Lab Delo. 1980;(11):694-5. Russian. PMID: 6160314.
Copy Download .nbib Format: NLM
Two Novel Mutations Associated With Ataxia-Telangiectasia Identified Using an Ion AmpliSeq Inherited Disease Panel.

Frontiers in neurology

Kuznetsova MV, Trofimov DY, Shubina ES, Kochetkova TO, Karetnikova NA, Barkov IY, Bakharev VA, Gusev OA, Sukhikh GT.
PMID: 29163336
Front Neurol. 2017 Oct 30;8:570. doi: 10.3389/fneur.2017.00570. eCollection 2017.

Ataxia-telangiectasia (A-T), or Louis-Bar syndrome, is a rare neurodegenerative disorder associated with immunodeficiency. For families with at least one affected child, timely A-T genotyping during any subsequent pregnancy allows the parents to make an informed decision about whether to...

Cite
Kuznetsova MV, Trofimov DY, Shubina ES, et al. Two Novel Mutations Associated With Ataxia-Telangiectasia Identified Using an Ion AmpliSeq Inherited Disease Panel. Front Neurol. 2017;8:570doi: 10.3389/fneur.2017.00570.
Kuznetsova, M. V., Trofimov, D. Y., Shubina, E. S., Kochetkova, T. O., Karetnikova, N. A., Barkov, I. Y., Bakharev, V. A., Gusev, O. A., & Sukhikh, G. T. (2017). Two Novel Mutations Associated With Ataxia-Telangiectasia Identified Using an Ion AmpliSeq Inherited Disease Panel. Frontiers in neurology, 8570. https://doi.org/10.3389/fneur.2017.00570
Kuznetsova, Maria V, et al. "Two Novel Mutations Associated With Ataxia-Telangiectasia Identified Using an Ion AmpliSeq Inherited Disease Panel." Frontiers in neurology vol. 8 (2017): 570. doi: https://doi.org/10.3389/fneur.2017.00570
Kuznetsova MV, Trofimov DY, Shubina ES, Kochetkova TO, Karetnikova NA, Barkov IY, Bakharev VA, Gusev OA, Sukhikh GT. Two Novel Mutations Associated With Ataxia-Telangiectasia Identified Using an Ion AmpliSeq Inherited Disease Panel. Front Neurol. 2017 Oct 30;8:570. doi: 10.3389/fneur.2017.00570. eCollection 2017. PMID: 29163336; PMCID: PMC5670107.
Copy Download .nbib Format: NLM
Platinum acetate blue: synthesis and characterization.

Inorganic chemistry

Cherkashina NV, Kochubey DI, Kanazhevskiy VV, Zaikovskii VI, Ivanov VK, Markov AA, Klyagina AP, Dobrokhotova ZV, Kozitsyna NY, Baranovsky IB, Ellert OG, Efimov NN, Nefedov SE, Novotortsev VM, Vargaftik MN, Moiseev II.
PMID: 25102316
Inorg Chem. 2014 Aug 18;53(16):8397-406. doi: 10.1021/ic500940a. Epub 2014 Aug 07.

Platinum acetate blue (PAB) of the empirical formula Pt(OOCMe)2.5±0.25, a byproduct in the synthesis of crystalline platinum(II) acetate Pt4(OOCMe)8, is an X-ray amorphous substance containing platinum in the oxidation state between (II) and (III). Typical PAB samples were studied...

Cite
Cherkashina NV, Kochubey DI, Kanazhevskiy VV, et al. Platinum acetate blue: synthesis and characterization. Inorg Chem. 2014;53(16):8397-406doi: 10.1021/ic500940a.
Cherkashina, N. V., Kochubey, D. I., Kanazhevskiy, V. V., Zaikovskii, V. I., Ivanov, V. K., Markov, A. A., Klyagina, A. P., Dobrokhotova, Z. V., Kozitsyna, N. Y., Baranovsky, I. B., Ellert, O. G., Efimov, N. N., Nefedov, S. E., Novotortsev, V. M., Vargaftik, M. N., & Moiseev, I. I. (2014). Platinum acetate blue: synthesis and characterization. Inorganic chemistry, 53(16), 8397-406. https://doi.org/10.1021/ic500940a
Cherkashina, Natalia V, et al. "Platinum acetate blue: synthesis and characterization." Inorganic chemistry vol. 53,16 (2014): 8397-406. doi: https://doi.org/10.1021/ic500940a
Cherkashina NV, Kochubey DI, Kanazhevskiy VV, Zaikovskii VI, Ivanov VK, Markov AA, Klyagina AP, Dobrokhotova ZV, Kozitsyna NY, Baranovsky IB, Ellert OG, Efimov NN, Nefedov SE, Novotortsev VM, Vargaftik MN, Moiseev II. Platinum acetate blue: synthesis and characterization. Inorg Chem. 2014 Aug 18;53(16):8397-406. doi: 10.1021/ic500940a. Epub 2014 Aug 07. PMID: 25102316.
Copy Download .nbib Format: NLM
Composition-tunable optical properties of colloidal IV-VI quantum dots, composed of core/shell heterostructures with alloy components.

ACS nano

Maikov GI, Vaxenburg R, Sashchiuk A, Lifshitz E.
PMID: 20945884
ACS Nano. 2010 Nov 23;4(11):6547-56. doi: 10.1021/nn101760t. Epub 2010 Oct 14.

Colloidal quantum dots (CQDs) attract worldwide scientific and technological attention due to the ability to engineer their optical properties by the variation of their size. However, several important applications, such as biological tagging and photovoltaic cells, impose a limit...

Cite
Maikov GI, Vaxenburg R, Sashchiuk A, et al. Composition-tunable optical properties of colloidal IV-VI quantum dots, composed of core/shell heterostructures with alloy components. ACS Nano. 2010;4(11):6547-56doi: 10.1021/nn101760t.
Maikov, G. I., Vaxenburg, R., Sashchiuk, A., & Lifshitz, E. (2010). Composition-tunable optical properties of colloidal IV-VI quantum dots, composed of core/shell heterostructures with alloy components. ACS nano, 4(11), 6547-56. https://doi.org/10.1021/nn101760t
Maikov, Georgy I, et al. "Composition-tunable optical properties of colloidal IV-VI quantum dots, composed of core/shell heterostructures with alloy components." ACS nano vol. 4,11 (2010): 6547-56. doi: https://doi.org/10.1021/nn101760t
Maikov GI, Vaxenburg R, Sashchiuk A, Lifshitz E. Composition-tunable optical properties of colloidal IV-VI quantum dots, composed of core/shell heterostructures with alloy components. ACS Nano. 2010 Nov 23;4(11):6547-56. doi: 10.1021/nn101760t. Epub 2010 Oct 14. PMID: 20945884.
Copy Download .nbib Format: NLM
Kinetics of surfactant-mediated epitaxial growth.

Physical review. B, Condensed matter

Markov I.
PMID: 9975255
Phys Rev B Condens Matter. 1994 Oct 15;50(15):11271-11274. doi: 10.1103/physrevb.50.11271.

No abstract available.

Cite
Markov I. Kinetics of surfactant-mediated epitaxial growth. Phys Rev B Condens Matter. 1994;50(15):11271-11274doi: 10.1103/physrevb.50.11271.
Markov, I. (1994). Kinetics of surfactant-mediated epitaxial growth. Physical review. B, Condensed matter, 50(15), 11271-11274. https://doi.org/10.1103/physrevb.50.11271
Markov. "Kinetics of surfactant-mediated epitaxial growth." Physical review. B, Condensed matter vol. 50,15 (1994): 11271-11274. doi: https://doi.org/10.1103/physrevb.50.11271
Markov I. Kinetics of surfactant-mediated epitaxial growth. Phys Rev B Condens Matter. 1994 Oct 15;50(15):11271-11274. doi: 10.1103/physrevb.50.11271. PMID: 9975255.
Copy Download .nbib Format: NLM
Erratum to: Laurate Permeates the Paracellular Pathway for Small Molecules in the Intestinal Epithelial Cell Model HT-29/B6 via Opening the Tight Junctions by Reversible Relocation of Claudin-5.

Pharmaceutical research

Dittmann I, Amasheh M, Krug SM, Markov AG, Fromm M, Amasheh S.
PMID: 25534681
Pharm Res. 2015 Feb;32(2):737. doi: 10.1007/s11095-014-1376-5.

No abstract available.

Cite
Dittmann I, Amasheh M, Krug SM, et al. Erratum to: Laurate Permeates the Paracellular Pathway for Small Molecules in the Intestinal Epithelial Cell Model HT-29/B6 via Opening the Tight Junctions by Reversible Relocation of Claudin-5. Pharm Res. 2015;32(2):737doi: 10.1007/s11095-014-1376-5.
Dittmann, I., Amasheh, M., Krug, S. M., Markov, A. G., Fromm, M., & Amasheh, S. (2015). Erratum to: Laurate Permeates the Paracellular Pathway for Small Molecules in the Intestinal Epithelial Cell Model HT-29/B6 via Opening the Tight Junctions by Reversible Relocation of Claudin-5. Pharmaceutical research, 32(2), 737. https://doi.org/10.1007/s11095-014-1376-5
Dittmann, Isabel, et al. "Erratum to: Laurate Permeates the Paracellular Pathway for Small Molecules in the Intestinal Epithelial Cell Model HT-29/B6 via Opening the Tight Junctions by Reversible Relocation of Claudin-5." Pharmaceutical research vol. 32,2 (2015): 737. doi: https://doi.org/10.1007/s11095-014-1376-5
Dittmann I, Amasheh M, Krug SM, Markov AG, Fromm M, Amasheh S. Erratum to: Laurate Permeates the Paracellular Pathway for Small Molecules in the Intestinal Epithelial Cell Model HT-29/B6 via Opening the Tight Junctions by Reversible Relocation of Claudin-5. Pharm Res. 2015 Feb;32(2):737. doi: 10.1007/s11095-014-1376-5. PMID: 25534681.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 73 entries